Copyright
©The Author(s) 2016.
World J Cardiol. Jan 26, 2016; 8(1): 98-111
Published online Jan 26, 2016. doi: 10.4330/wjc.v8.i1.98
Published online Jan 26, 2016. doi: 10.4330/wjc.v8.i1.98
Figure 1 Flow-chart of the study selection process.
IABP: Intra-aortic balloon pump; PLVADs: Percutaneous left ventricular assist devices; ECMO: Extracorporeal membrane oxygenation.
Figure 2 Meta-analysis on risk ratio of inhospital mortality between the patients with intra-aortic balloon pump vs medical therapy.
Figure 3 Intra-aortic balloon pump vs medical therapy: Trial Sequential Analysis on inhospital mortality.
IABP: Intra-aortic balloon pump.
Figure 4 Meta-analysis on risk ratio of late mortality between the patients with intra-aortic balloon pump vs medical therapy.
Figure 5 Meta-analysis on risk ratio of inhospital mortality between the patients with percutaneous left ventricular assist devices vs intra-aortic balloon pump.
IABP: Intra-aortic balloon pump; PLVADs: Percutaneous left ventricular assist devices.
Figure 6 Meta-analysis on risk ratio of inhospital mortality between the patients with extracorporeal membrane oxygenation plus Intra-aortic balloon pump vs intra-aortic balloon pump or extracorporeal membrane oxygenation alone.
IABP: Intra-aortic balloon pump; ECMO: Extracorporeal membrane oxygenation.
Figure 7 Extracorporeal membrane oxygenation plus Intra-aortic balloon pump support vs Intra-aortic balloon pump alone: Trial Sequential Analysis on inhospital mortality.
IABP: Intra-aortic balloon pump; ECMO: Extracorporeal membrane oxygenation.
- Citation: Romeo F, Acconcia MC, Sergi D, Romeo A, Francioni S, Chiarotti F, Caretta Q. Percutaneous assist devices in acute myocardial infarction with cardiogenic shock: Review, meta-analysis. World J Cardiol 2016; 8(1): 98-111
- URL: https://www.wjgnet.com/1949-8462/full/v8/i1/98.htm
- DOI: https://dx.doi.org/10.4330/wjc.v8.i1.98